The studies by Anholm C, et al
Methods In this retrospective cohort study using real-world clinical data, we matched 3435 tirzepatide-exposed (180 days treatment) individuals with type 2 diabetes 1:1 with 3434 tirzepatide-unexposed individuals for sex, diabetes duration, retinopathy status, HbA 1c , number of retinal screening episodes and use of glucose-lowering medications
Is semaglutide GLP-1 effective for everyone in suppressing appetite
Also, these lifestyle changes help maintain your weight loss results after stopping the medication
doi:10.1016/j.pmrj.2011.03.008 40GilronI, BaileyJM, TuD, HoldenRR, JacksonAC, HouldenRL
In a study analyzing the cessation of Evista in women treated for postmenopausal osteoporosis, bone density markers returned to baseline levels after 120 weeks, with the positive effects on bone turnover lost 6 months post-treatment